Related Experiment Video

Updated: Aug 11, 2026

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
13:08

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Published on: September 9, 2011

Treatment of chronic recurrent multifocal osteomyelitis with interferon gamma

K T Gallagher1, R L Roberts, J A MacFarlane

  • 1Department of Pediatrics, University of California, Los Angeles School of Medicine 90095-1752, USA.

The Journal of Pediatrics
|November 5, 1997
PubMed

Insights

Interferon gamma therapy offers a promising treatment for chronic recurrent multifocal osteomyelitis, a painful bone condition. This treatment successfully prevented new episodes in a young patient, indicating a significant therapeutic response.

Area of Science:

  • Immunology
  • Pediatric Osteology
  • Rheumatology

Background:

  • Chronic recurrent multifocal osteomyelitis (CRMO) presents as recurrent, painful bone lesions unresponsive to antibiotics.
  • CRMO mimics infectious osteomyelitis but lacks bacterial confirmation and shows no antibiotic efficacy.

Observation:

  • A 13-year-old female patient experienced frequent CRMO episodes (11 in 2.5 years).
  • The patient presented with painful, swollen bone and skin lesions, radiographic changes, and elevated sedimentation rates.

Findings:

  • Treatment with interferon gamma for 3 months resulted in a complete cessation of CRMO episodes.
  • The patient remained symptom-free for 15 months post-therapy, demonstrating a sustained positive outcome.

Implications:

  • Interferon gamma represents a potential novel therapeutic strategy for managing chronic recurrent multifocal osteomyelitis.
  • This case highlights the efficacy of immunomodulatory therapy in refractory pediatric bone inflammatory conditions.

More Related Videos

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection09:11

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection

Published on: July 16, 2019

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...